Literature DB >> 26739795

Hypertension in pregnancy and long-term cardiovascular mortality: a retrospective cohort study.

Jane Tooher1, Charlene Thornton2, Angela Makris3, Robert Ogle4, Andrew Korda2, John Horvath5, Annemarie Hennessy2.   

Abstract

BACKGROUND: There is growing evidence that hypertensive disorders of pregnancy are associated with increased long-term cardiovascular mortality in the mother. Hypertension in pregnancy, until recently, however, has been ignored largely as a risk factor for future cardiovascular disease and mortality because the link between the 2 is not fully understood.
OBJECTIVE: To determine the association between women with hypertension in pregnancy and long-term cardiovascular disease mortality. STUDY
DESIGN: All women who delivered at a metropolitan hospital between the periods of January 1, 1980, and December 31, 1989, were identified by use of the International Statistical Classification of Diseases and Related Health Problems, 9th Revision, Australian Modification.
RESULTS: The total number of deliveries in the given time period was 31,656, with 4387 (14%) of the women identified as having had hypertension in their pregnancy. Using information from the New South Wales Births, Deaths and Marriages Registry and the Australian Bureau of Statistics Death Registry, we identified a total of 651 deaths from this cohort (n = 31,656). There were 521 deaths among the women who remained normotensive in their pregnancy and 129 deaths for women who had hypertension during their pregnancy. Overall, the women with hypertensive disorders of pregnancy were at greater risk of death than the women who remained normotensive in their pregnancy (odds ratio 1.56; 95% confidence interval 1.28-1.89; P < .001).
CONCLUSION: Women with a history of hypertension in their pregnancy are at an increased risk of future cardiovascular mortality, and this work identifies a group of women who may benefit from early screening and intervention strategies to help decrease their risk of future cardiovascular disease. Crown
Copyright © 2015. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cardiovascular disease; hypertension; mortality; preeclampsia; pregnancy

Mesh:

Year:  2015        PMID: 26739795     DOI: 10.1016/j.ajog.2015.12.047

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  12 in total

Review 1.  Preeclampsia and health risks later in life: an immunological link.

Authors:  Shi-Bin Cheng; Surendra Sharma
Journal:  Semin Immunopathol       Date:  2016-06-23       Impact factor: 9.623

2.  ELABELA plasma concentrations are increased in women with late-onset preeclampsia.

Authors:  Bogdan Panaitescu; Roberto Romero; Nardhy Gomez-Lopez; Percy Pacora; Offer Erez; Felipe Vadillo-Ortega; Lami Yeo; Sonia S Hassan; Chaur-Dong Hsu
Journal:  J Matern Fetal Neonatal Med       Date:  2018-07-22

3.  An external exposome-wide association study of hypertensive disorders of pregnancy.

Authors:  Hui Hu; Jinying Zhao; David A Savitz; Mattia Prosperi; Yi Zheng; Thomas A Pearson
Journal:  Environ Int       Date:  2020-05-12       Impact factor: 9.621

4.  A Maternally Sequestered, Biopolymer-Stabilized Vascular Endothelial Growth Factor (VEGF) Chimera for Treatment of Preeclampsia.

Authors:  Omar C Logue; Fakhri Mahdi; Heather Chapman; Eric M George; Gene L Bidwell
Journal:  J Am Heart Assoc       Date:  2017-12-08       Impact factor: 5.501

5.  Recognizing Cardiovascular Risk After Preeclampsia: The P4 Study.

Authors:  Mark A Brown; Lynne Roberts; Anna Hoffman; Amanda Henry; George Mangos; Anthony O'Sullivan; Franziska Pettit; George Youssef; Lily Xu; Gregory K Davis
Journal:  J Am Heart Assoc       Date:  2020-11-10       Impact factor: 5.501

Review 6.  Use of Race, Ethnicity, and National Origin in Studies Assessing Cardiovascular Risk in Women With a History of Hypertensive Disorders of Pregnancy.

Authors:  Amy Johnston; Victrine Tseung; Sonia R Dancey; Sarah M Visintini; Thais Coutinho; Jodi D Edwards
Journal:  CJC Open       Date:  2021-08-20

Review 7.  Blood Pressure Variability in Pregnancy: an Opportunity to Develop Improved Prognostic and Risk Assessment Tools.

Authors:  Jane V Vermunt; Stephen H Kennedy; Vesna D Garovic
Journal:  Curr Hypertens Rep       Date:  2020-02-01       Impact factor: 5.369

8.  Low-dose aspirin at ≤16 weeks of gestation for preventing preeclampsia and its maternal and neonatal adverse outcomes: A systematic review and meta-analysis.

Authors:  Yuechong Cui; Bin Zhu; Fei Zheng
Journal:  Exp Ther Med       Date:  2018-03-20       Impact factor: 2.447

Review 9.  Hypertensive Disorders of Pregnancy and Future Maternal Cardiovascular Risk.

Authors:  Wendy Ying; Janet M Catov; Pamela Ouyang
Journal:  J Am Heart Assoc       Date:  2018-09-04       Impact factor: 5.501

10.  A Protocol for Nurse-Practitioner Led Cardiovascular Follow-Up After Pregnancy Complications in a Socioeconomically Disadvantaged Population.

Authors:  Emily Aldridge; Petra E Verburg; Susan Sierp; Prabha Andraweera; Gustaaf A Dekker; Claire T Roberts; Margaret A Arstall
Journal:  Front Cardiovasc Med       Date:  2020-01-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.